Juvenile xanthogranuloma: a case report and review of the literature by Laura Pajaziti et al.
Pajaziti et al. BMC Research Notes 2014, 7:174
http://www.biomedcentral.com/1756-0500/7/174CASE REPORT Open AccessJuvenile xanthogranuloma: a case report and
review of the literature
Laura Pajaziti1*, Syzana Rexhepi Hapçiu1 and Artina Pajaziti2Abstract
Background: Juvenile xanthogranuloma is a rare disorder which may be present at birth, or appears in infancy. It
can also occur in adults of all ages; appears with lesions that may be solitary or multiple nodules several millimeters
in diameter. The predilection sites are head and neck, but it may occur on the extremities and trunk also. There can
also be involved internal organs such as lung, kidney, gastrointestinal tract, etc. The most frequent extracutaneous
location is the eye.
Case presentation: We report a case of juvenile xanthogranuloma in a male child with onset in the fourth month
of life. He presented with a nodule 8 millimeters in diameter, tan-orange in color, ulcerated in the centre, located
on the left corner of the left eye. A biopsy without total excision was performed. After the biopsy, the nodule
enlarged to 1.5 cm in diameter and became haemorrhagic. The histologic evaluation and immunohistochemistry
analysis resulted in the diagnosis of juvenile xanthogranuloma. For aesthetic reasons the nodule was removed by
surgical resection.
Conclusion: Juvenile xanthogranuloma is on a spectrum of histiocytic disorders, which is necessary to
differentiate from maligniances in childhood by biopsy.
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Juvenile xanthogranuloma (JXG) is a rare disorder,
which belongs to the broad group of non - Langerhans
cell histiocytosis [1]. JXG may be present at birth, but it
mostly arises during the first year of life [2]. It is charac-
terized by one or more nodules with the predilection
sites on the head and neck, although the appearance on
the trunk, extremities and extracutaneous locations has
been reported also [3,4]. Skin lesions are self- limited
and vary in size. They are reddish or yellowish benign
papules or nodules, which do not require treatment
[4,5]. The eye, particularly the uveal tract, is the most
frequent site of extracutaneous involvement [6].
Histologically, JXG is composed of collections of his-
tiocytes, foamy cells and Touton giant cells. The diagno-
sis of JXG is mainly clinical, but sometimes a biopsy
analysis is required [7].* Correspondence: laurapajaziti@gmail.com
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spontaneous resolution. Extracutaneous lesions are rare
and can be associated with morbidity.
Case presentation
A five-month-old male presented with a nodule in the left
corner of the left eye. He was born at 40 weeks’ gestational
age, without any abnormality or history of trauma at birth.
The lesion was first noted at four months of age. The nod-
ule was 8 millimeters in diameter, tan-orange in color,
with central ulceration.
His parents consulted a maxillofacial surgeon, who took
a partial biopsy from the nodule. After the biopsy, the
nodule enlarged and became hemorrhagic and the parents
brought their child to the Clinic of Dermatology (Figure 1).
In mean time the histological evaluation revealed ulcer-
ated cutaneous cellular proliferation, diffuse infiltrates of
mononucleated cells, some of which are characterized by
their reniform nuclei, foamy histiocytes and numerous
Touton giant cells, admixed with eosinophils.
Immunohistochemistry yielded results immunoreactive
for CD68, weak focal positivity for S-100 protein, butLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The enlarged nodule after partial biopsy.
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histiocytes are non-Langerhans cells.
After the diagnosis was made, the child was treated by
an ophthalmologist, and examination was within normal
limits.
Discussion
JXG is a benign cutaneous fibrohistiocytic lesion and a
type of granulomatous process [3]. Even though the
etiology is unknown, it is believed to result from disor-
dered macrophage response to the nonspecific injury
[6]. The main clinical feature is papulonodular lesion,
tan – orange in color and several millimeters in diam-
eter, which may be single or multiple. The predilection
sites of occurence are the skin of head and neck, but
these papulonodular lesions may occur on the trunk
and extremities also. The eye is the most frequent
extracutaneous location of JXG. Ocular involvement
may occur without concomitant skin involvement.
0.5% of patients with cutaneous JXG are reported with
ocular involvement [6,8], although in some studies it is
reported a higher incidence [6,9]. Children with mul-
tiple skin lesions and those who are younger than
2 years are at greater risk for ocular involvement [3,6].
Other extracutaneous locations of JXG are the lung,heart, gastrointestinal system, central nervous system,
adrenal gland, pituitary gland, bones, bone marrow,
and kidney.
JXG was reported by H.G. Adamson in 1905 [10]
and named in 1954 describing the appearance of cells
under microscope [11]. In about 10% of cases may be
present at birth, but mainly affects infants and small
children. According to Zimmerman 64% of cutaneous
lesions are by age 7 months and 85% before 1 year [6].
The appearance of multiple lesions is more frequent
in children younger than 6 months [3], which is not
our case. JXG may occur in adults of all ages too, but
this onset is infrequent and tend to be more compli-
cated [12].
The male to female ratio of cutaneous JXG is about
1.4:1 in children, while in adults no sex predilection
exists [12].
Since the disease is often clinically diagnosed and not
always confirmed histologically, sometimes is misdiag-
nosed. On the other hand, spontaneous regression of the
cutaneous lesions is frequent. Therefore, the incidence
of the diseased with JXG is unknown. In a survey of 122
dermatologists with an average of 12 years of practice,
less than two cases per dermatologist per year were re-
ported [12].
The diagnosis of JXG is mainly based on characteristic
clinical features. The clinical differential diagnosis includes
spitz nevi, mastocytomas and dermatofibromas [1].
The confirmation of clinical diagnosis can be made by
skin biopsy.
Characteristic histologic findings in JXG are: dense
dermal histiocytic infiltrate and Touton Giant cells
which are multinucleated, with homogeneous eosino-
philic cytoplasmic center and xanthomatization in the
periphery [7].
Immunohistochemistry has an important role in the dif-
ferential diagnosis between Langerhans cell histiocytosis
(LCH) and JXG [3]. JXG lesions usually label strongly with
markers CD68, factor XIIIa and often anti CD4 [13,14].
S-100 protein immunoreactivity, which is a marker for
the diagnosis of LCH, is typically absent [13,14]. In most
cases with JXG, S-100 protein was non reactive, but
scattered cells may show weak cytoplasmic reactivity,
unlike the more diffuse and intense reaction of Langer-
hans cells [15]. According to Dehner, neither factor
XIIIa negativity, nor S-100 positivity should preclude
the diagnosis of JXG [1].Conclusions
JXG is self-limited disorder and skin lesions usually
resolve spontaneously. Treatment is required on
those with extracutaneous involvement, who may
have increased morbidity. Sometimes the excision is
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our case, the nodule enlarged and became haemor-
rhagic after partial biopsy. In order for proper diag-
nosis and for aesthetic reasons the removal of nodule
must be complete.
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